High materiality8/10
Agios Pharmaceuticals price target lowered to $52 from $54 at H.C. Wainwright
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target trimmed to $52 from $54; current price $37.77. Despite the trim, the target remains well above the current price, signaling upside potential.
- Target trimmed but remains above current price; upside to $52.
Key facts
- 01
Target: $52
- 02
Posted price: $37.77
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Emily Bodnar
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.